SCHEMBL22632229

SCHEMBL22632229

CNCCc1cc(=O)oc2cc(N(C)C)ccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC18A1 P54219 1/20 0.50
▸ SLC18A2 Q05940 1/20 0.50
▸ CYP2D6 P10635 3/20 0.47
▸ HSD17B3 P37058 4/20 0.47
▸ IGLV6-57 P01721 2/20 0.46
▸ ALDH1A1 P00352 6/20 0.45
▸ GAA P10253 1/20 0.45
▸ ERAP1 Q9NZ08 1/20 0.45
▸ HPGD P15428 4/20 0.45
▸ KDM4E B2RXH2 4/20 0.45
▸ MAPT P10636 3/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ LMNA P02545 2/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ NR4A1 P22736 1/20 0.45
▸ MCL1 Q07820 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ SAE1 Q9UBE0 1/20 0.45
▸ UBA2 Q9UBT2 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24623256 0.86 IGLV6-57 (0.46) SLC18A1SLC18A2CYP2D6HSD17B3IGLV6-57
SCHEMBL22632228 0.85 MTNR1A (0.58) SLC18A1SLC18A2CYP2D6HSD17B3IGLV6-57
SCHEMBL6689431 0.83 HSD17B3 (0.62) CYP2D6HSD17B3IGLV6-57ALDH1A1GAA
SCHEMBL24623285 0.82 ALDH1A1 (0.44) SLC18A1SLC18A2CYP2D6HSD17B3IGLV6-57
SCHEMBL22632227 0.81 SLC18A1 (0.59) SLC18A1SLC18A2CYP2D6HSD17B3ALDH1A1
SCHEMBL6417463 0.80 ALDH1A1 (0.60) CYP2D6HSD17B3IGLV6-57ALDH1A1GAA
SCHEMBL2627650 0.79 KDM4E (0.50) CYP2D6HSD17B3ALDH1A1GAAHPGD
SCHEMBL22632088 0.79 SLC18A1 (0.54) SLC18A1SLC18A2CYP2D6HSD17B3ALDH1A1
SCHEMBL22632087 0.78 CYP2D6 (0.76) CYP2D6ALDH1A1GAAHPGDKDM4E
SCHEMBL10878198 0.78 HSD17B3 (0.65) HSD17B3IGLV6-57ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020223174-A1 COUMARIN-MODIFIED ANDROGENS FOR THE TREATMENT OF PROSTATE CANCER HEALTH RESEARCH, INC. (US) 2020-11-05 — — WO disclosed
Send feedback